Bruker (Nasdaq:BRKR) shares ticked up today on third-quarter financial results that beat the consensus forecast. Shares of BRKR rose 8.4% at $66.22 apiece as the market opened today. The Billerica, Massachusetts-based company posted profits of $88.1 million for the quarter. That amounts to 59¢ per share on sales of $638.9 million for the three months […]
Bruker Corp.
Bruker reports nearly 31% sales growth in Q1, increases full-year guidance
Bruker Corp. (NSDQ:BRKR) posted first-quarter results today that beat the overall consensus on Wall Street and raised its full-year guidance as a result. The Billerica, Mass.-based company reported profits of $56.7 million, or 37¢ per share, on sales of $554.7 million for the three months ended March 31, for a bottom-line gain of 440% sales growth […]
Bruker slides on Street-beating Q3 results
Bruker Corp. (NSDQ:BRKR) posted third-quarter results that beat the consensus on Wall Street. The Billerica, Mass.-based company reported profits of $54.3 million, or 35¢ per share, on sales of $511.4 million for the three months ended Sept. 30, for a bottom-line loss of -11.4% sales loss of -1.9% compared with Q3 2019. Adjusted to exclude one-time […]
Bruker acquires Canopy Biosciences
Bruker Corp. (NSDQ:BRKR) announced today that it acquired biomarker imaging technology developer Canopy Biosciences. Billerica, Mass.-based Bruker said in a news release that the acquisition, for which financial details were not disclosed, enhances its offering in targeted multi-omics and fluorescence-based imaging technologies and combines its global reach with Canopy’s success to date. Canopy develops high multiplex […]
Medical device companies: These 15 performed the best in 2017
Updated Jan. 5, 2018 Among the most successful medical device companies of 2017, there were two themes: innovation and breadth of services. That was the major takeaway of an MDO analysis of the stock performance of the 100 largest publicly traded medtech companies in the world. What does innovation mean? Think Align Technology (Nasdaq:ALGN) and […]
Bruker inks deal for Oncovision imaging biz
Bruker Corp. (NSDQ:BRKR) said today it inked a deal to pick up Oncovision‘s preclinical imaging business for an undisclosed amount. Oncovision will retain its clinical human imaging business, including its Mammi PET breast cancer diagnostic tool, the companies said. “With this planned acquisition, Bruker expects to strengthen its expertise and leadership in preclinical imaging. The […]
Bayer taps strategy head Baumann for CEO | Personnel Moves
Bayer (ETR:BAYN) named strategy chief Werner Baumann to replace Marijn Dekkers as CEO today, prompting some industry watchers to speculate that there’s more deal-making ahead for the German firm’s non-pharma markets. Baumann, who’s slated to succeed Dekkers May 1, joined Bayer in 1988 and made a name for himself with the successful integration of rival drugmaker […]
Baxter adds Boston Scientific CEO Mahoney to board | Personnel Moves
Baxter (NYSE:BAX) said today that it named Boston Scientific (NYSE:BSX) CEO Mike Mahoney to its board of directors. Mahoney, who engineered a significant turnaround at Boston Scientific, was tapped to serve on Baxter’s governance and compensation committees. “Mike’s significant knowledge of the global medical products business and his track record of leadership will make a significant contribution […]
Ex-Wells Fargo trader slips SEC charges of insider trading
(Reuters) — A former Wells Fargo trader yesterday was cleared of insider trading charges brought by the U.S. Securities & Exchange Commission, after a major appellate decision limited authorities’ ability to pursue such cases. Following a trial before the regulator’s in-house court, Administrative Law Judge Jason Patil dismissed the charges against Joseph Ruggieri, who the SEC said […]
Guidant didn’t breach deal with J&J, says lawyer | Medtech legal news for the week of December 22, 2014
SEC dings Bruker in $2.4m China bribery case
